Utama › Kegagalan Jantung › Texas › Austin
Kajian klinikal Kegagalan Jantung di Austin, TX
18 kajian untuk Kegagalan Jantung sedang mencari peserta di lokasi dalam dan sekitar Austin (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
Alleviant ALLAY-HFrEF Study
Mengambil peserta
- Austin Heart, Austin
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
Mengambil pesertaFasa 3
- Austin Heart, Austin
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
Mengambil pesertaFasa 3
- Research Site, Austin
A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)
Mengambil pesertaFasa 3
- CON-10015 Austin, TX Investigational Site, Austin
The WiSE®-UP Study (The WiSE System Utilization & Performance Study)
Mengambil pesertaKajian pemerhatian
- Texas Cardiac Arrhythmia Research Foundation, Austin
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
Mengambil pesertaFasa 3
- Austin, TX Investigative Site 10015, Austin
Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
- Dell Children's Medical Center of Central Texas, Austin
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
Mengambil pesertaKajian pemerhatian
- Austin, Austin
LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2
Mengambil pesertaFasa 3
- Tenax Investigational Site, Austin
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Mengambil pesertaFasa 3
- Austin Heart, Austin
Alleviant ALLAY-HF Study
Mengambil peserta
- Austin Heart, Austin
Assessment of CCM in HF With Higher Ejection Fraction
Mengambil peserta
- Ascension Seton, Austin
- Austin Heart, Austin
A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With Heart Failure Who Are Intolerant or Not Eligible for Treatment With Steroidal Mineralocorticoid Receptor Antagonists
Mengambil pesertaFasa 3
- FIN-10015 Austin, TX Investigational Site, Austin
PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
Mengambil peserta
- Austin Heart, Austin
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
Mengambil peserta
- Ascension Texas Cardiovascular, Austin
AI-Enabled Direct-from-ECG Ejection Fraction (EF) Severity Assessment Using COR ECG Wearable Monitor
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
- Texas Cardiac Arrhythmia Research Foundation, Austin
Sensor-controlled Digital Game for Heart Failure Self-management: A Clinical Trial
Mengambil peserta
- The University of Texas Austin, Austin
HF2 Registry - Hemodynamic Frontiers in Heart Failure Registry
Mengambil pesertaKajian pemerhatian
- Austin Heart, Austin
Kajian Kegagalan Jantung di bandar lain
- New York City, NY51 kajian
- Boston, MA44 kajian
- Dallas, TX42 kajian
- Houston, TX36 kajian
- Cleveland, OH33 kajian
- Chicago, IL31 kajian
- Philadelphia, PA31 kajian
- San Francisco, CA29 kajian
- St. Louis, MO26 kajian
- Durham, NC26 kajian
- Atlanta, GA25 kajian
- Kansas City, MO25 kajian
Kajian lain di Austin
- Kanser Paru-paru Bukan Sel Kecil30 kajian
- Kanser (semua jenis)20 kajian
- Obesiti20 kajian
- Kanser Metastatik19 kajian
- Kanser Kolorektal19 kajian
- Kanser Payudara18 kajian
- Berat Badan Berlebihan18 kajian
- Kanser Ovari17 kajian
- Kanser Endometrium15 kajian
- Kanser Prostat15 kajian
- Depresi14 kajian
- Kanser Payudara Triple-Negatif13 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 4 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.